Close this search box.

Clinical Trial: ALLIANCE A031902


Status: Closed

CASPAR – A Phase III Trial of Enzalutamide and Rucaparib as a Novel Therapy in First-Line Metastatic Castration-Resistant Prostate Cancer

A031902 pre-registration and registration is closed to new patient accrual, effective  October 2, 2023.

A031902 is temporarily suspended to new patient registration (OPEN Step 2), effective  May 10, 2023.